Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Adenosine Receptor Activity Assay from US Patent US11974991: "Adenosine receptor activity of methyl/ethyl 3-(substituted benzoyl)-6,8-dimethylindolizine-2-substituted-1-carboxylates"
Assay data:11 Active, 5 Activity ≤ 1 µM, 13 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by Target
Adenosine Receptor Time-Resolved Fluorescence Resonance Energy Transfer (TRFRET) Binding Assay from US Patent US20240083904: "ANTAGONISTS OF THE ADENOSINE A2A RECEPTOR"
Assay data:13 Active, 10 Activity ≤ 1 nM, 13 Activity ≤ 1 µM, 13 Tested
Adenosine A3 Eurofins Panlabs panel
Assay data:1 Tested
SummaryRelated BioAssays by Target
Binding affinity towards human ADORA3 (agonistic activity) in an in vitro assay with cellular components measured by scintillation counting
Assay data:92 Active, 18 Activity ≤ 1 µM, 754 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Target
Binding affinity towards human ADORA3 in an in vitro assay with cellular components measured by scintillation proximity assay
Assay data:82 Active, 4 Activity ≤ 1 µM, 1215 Tested
Inhibition of Adenosine A3 receptor (unknown origin) at 10 uM
SummaryPubMed CitationRelated BioAssays by Target
Binding affinity to mouse adenosine A3 receptor assessed as inhibition constant
Assay data:4 Tested
Binding affinity to rat adenosine A3 receptor assessed as inhibition constant
Assay data:1 Active, 1 Tested
SummaryCompounds, ActivePubMed CitationRelated BioAssays by Target
Binding affinity to human adenosine A3 receptor assessed as inhibition constant
Assay data:3 Active, 3 Activity ≤ 1 µM, 4 Tested
Inhibition of A3 adenosine receptor (unknown origin)
Inhibition of human A3 adenosine receptor
Assay data:2 Tested
Inhibition of human A3 adenosine receptor assessed as inhibition constant
Binding affinity to human A3 adenosine receptor assessed as inhibition constant
Assay data:2 Active, 1 Activity ≤ 1 nM, 2 Activity ≤ 1 µM, 2 Tested
Displacement of [1251]AB-MEC from human A3 receptor assessed as inhibition constant
Assay data:1 Active, 1 Activity ≤ 1 µM, 1 Tested
Displacement of f [125I]ABA to human A3 adenosine receptor derived from CHO cell membrane assessed as inhibition constant
Adenosine Receptor Binding Assay from US Patent US20230416245: "ADENOSINE ANALOGS FOR THE TREATMENT OF DISEASE"
Assay data:23 Active, 5 Activity ≤ 1 nM, 23 Activity ≤ 1 µM, 24 Tested
SPR Assay from US Patent US11786528: "Pyrazolopyrimidine compounds as adenosine receptor antagonists"
Assay data:46 Active, 46 Activity ≤ 1 µM, 46 Tested
Adenosine Receptor Time-Resolved Fluorescence Resonance Energy Transfer (TRFRET) Binding Assay from US Patent US20230293517: "ANTAGONIST COMPOUNDS"
Assay data:258 Active, 137 Activity ≤ 1 nM, 258 Activity ≤ 1 µM, 258 Tested
Binding Affinities to Different Adenosine Receptors from US Patent US11629147: "Triazolo-pyrimidine compounds and uses thereof"
Assay data:21 Active, 5 Activity ≤ 1 nM, 21 Activity ≤ 1 µM, 21 Tested
Selectivity interaction (CEREP panel (GPCRS, ion channels, transporters)) EUB0000193b ADORA3
SummaryCompounds, ActiveRelated BioAssays by Target
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on